 - Other past or current malignancy with the exception of basal cell carcinoma or the skin or in situ carcinoma of the cervix or breasts unless the tumor was successfully treated with curative intent at least 2 years prior to trial entry except if in the opinion of the investigator and medical monitor it is thought not to affect the subjects safety, the conduct of the study or the interpretation of the data 